Webinar: 2023 Healthcare Market Trends, Innovation and Disruptions to Watch

Sg2, Vizient’s market growth and strategy company, will present leading healthcare trends to help industry partners understand market dynamics that drive opportunities for growth in the evolving healthcare landscape. Gain key insights into how markets differ in their evolution towards the move to non-acute sites of care while getting an update on the emerging innovation and disruption we expect to have the largest impact through the year ahead.

In this webinar, you will:

• Understand the evolving healthcare landscape and how it will impact your organization.
• Understand top trends we’re tracking in 2023 and how we expect them to impact industry
• How are health systems balancing strategic efforts to manage/ grow the portfolio of services while reigning in cost?
• How the convergence of technology, new entrants and site of care shifts are compelling health systems to renew its focus on the consumer

About the Speakers:

Amy Brouhle, RN, BSN, MBA, MHA,
National Vice President, Supplier Strategy and Business Development

Amy has over 25 years of experience in the health care arena and has held positions spanning a variety of segments including strategy, business development, consulting, as well as operational and clinical services.  

In her current role, Amy has responsibility for our overall supplier solutions strategy while leading a team of specialized resources tasked with delivering value to our supplier partners through data, market insights, technology, and contract services. In addition, Amy leads the Sg2 Life Science and Industry market development efforts which includes supplier education, national speaking engagements and delivery of strategically aligned market insights.  

Prior to her current role, Amy served as a vice president at Sg2, responsible for driving new business for Sg2 in the supplier segment of the market, which includes pharmaceutical, medical device and life science companies. She focused on identifying emerging trends, industry disruption and partnership opportunities for life science organizations to leverage for growth, and she helped prioritize IDN segmentation and innovation. Prior to her Life Science and Industry role at Sg2, she was accountable for growing new sales in the Western region of the United States, including California and Texas for the provider segment of the market.  

Before joining Sg2, she worked with Press Ganey Associates, Inc, and most recently served as vice president of ambulatory services, where she was responsible for the strategic direction, revenue growth, product development, regulatory alliance, sales messaging and marketing of the ambulatory service lines. She also managed product development and collaborated with marketing and sales as vice president of client enterprise solutions, and she provided marketplace and regulatory expertise to large medical practices seeking to grow market share as director of medical services, among other Press Ganey Associates duties and roles.  

Additionally, Amy has held positions with GE Healthcare, Per-Se Technologies and the TriZetto Group, Inc. She has extensive consulting experience in medical practice start-ups, physician compensation planning and revenue cycle reengineering. She began her career as a registered nurse, focused in Emergency Medicine and Critical Care.

Amy holds a master of business administration and a master of health administration from the University of Colorado Denver, and she has a bachelor of science in nursing from the University of Virginia.

Jeffrey Moser
Principal, Sg2

As a thought leader on enterprise strategy, Jeff prepares both health system and life sciences & industry clients by helping them understand the implications of both macro- and microlevel emerging trends impacting health care. He plays a key role in the development of Sg2 Intelligence resources and educational offerings and is a frequent presenter and educator on multiple topics, including spend management, consumerism and patient engagement, ambulatory strategy, value based care, and leading practices in care redesign. 

Jeff has more than 28 years of health care advisory and consulting experience, with specific areas of expertise including strategic planning, operational effectiveness and organizational change. 

Before joining Sg2, Jeff was the vice president of assessments at Cardinal Health in Dublin, OH, where he identified opportunities for improvement and recommended specific strategies to client organizations. He also led health care consulting projects focused on improving profitability, quality and service for both specific departments and entire organizations. During his tenure, Jeff helped identify opportunities that yielded an average of 12% operating improvement. In his last 5 years, he participated in or led an average of 15 assessments per year. He was integral to the development of Cardinal Health’s “patient throughput” product in 2002.  

Prior to his work at Cardinal Health, Jeff served as a project director for West Hudson, Inc (now part of Cardinal Health). There, he facilitated the implementation of hospital-based quality-, service- and cost-related process improvements both inter- and intradepartmentally. 

Jeff received an MS in organizational psychology from Springfield College in Massachusetts and a BS with a double major in economics and psychology from Texas Christian University. He also serves on the board of Colorado Health Institute.